Metraipolis › archive › dc_cfbba903b92e

Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41753059
DOI
10.3390/jcm15041371
License (as archived)
solo-consultazione
Archived
2026-11-06T00:47:13.316Z
SHA-256 of the archived text
4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf
Stable URL of this page
https://metraipolis.com/documento/dc_cfbba903b92e

How to cite

Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059 — Europe PMC (en), https://europepmc.org/article/MED/41753059 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfbba903b92e (Metraipolis archive dc_cfbba903b92e, sha256 4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf)
BibTeX
@misc{dccfbba903b92e,
  title = {Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41753059},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfbba903b92e; sha256 4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753059. Agents can read the archived copy with the MCP tool read_document.